The University of Exeter’s David Halpin, MA, DPhil, explains why GOLD 2026 treats a single COPD exacerbation as a trigger to ...

First-line IVF produced more live births than IUI within 7 months in couples with unexplained infertility.

The FDA granted accelerated approval to amivantamab and hyaluronidase for previously treated recurrent or metastatic head and ...

Michael Mina, MD, PhD, on why babies, immunocompromised patients, and the unvaccinated have the greatest need for a measles ...

The glucagon/GLP-1 dual agonist is noninferior to placebo for major adverse cardiovascular events and lowers blood pressure ...

Two decades ago, lung cancer was treated almost exclusively with cytotoxic chemotherapy. Today, immune checkpoint inhibitors anchor treatment regimens across nearly every stage of the disease, ...

Most patients with MASH stay on resmetirom at 1 year, but Medicaid coverage was tied to lower odds of filling a first ...

Six studies found liver transplant disparities by insurance, region, ethnicity, and sex, plus links between unmet social ...

Gut-derived bile acids disrupt liver metabolism through LRH-1 before visible damage, pointing to new early biomarkers for ...

In nonobese patients in the ESSENCE trial, semaglutide improved metabolic dysfunction even with modest weight loss of 2% to 5%.

Myeloma risk prediction is strong, but matching each patient to optimal therapy is still being tested, says Nikhil C. Munshi, ...

Phase 3 Viti-Up trials show Rinvoq (upadacitinib) JAK inhibitor boosts facial and body repigmentation in nonsegmental ...